Brief: VYNE Therapeutics Q3 Basic EPS USD -0.29
Nov 07 (Reuters) - VYNE Therapeutics Q3 EPS from cont ops USD -0.29. * Q3 revenue USD 121 thousand * Q3 net income USD -12.157 million
Nov 07 (Reuters) - VYNE Therapeutics Q3 EPS from cont ops USD -0.29. * Q3 revenue USD 121 thousand * Q3 net income USD -12.157 million